 | • レポートコード：MRC2-11QY12711 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はミトコンドリアミオパチー診断・治療のグローバル市場について調査・分析したレポートです。種類別（筋肉生検、血液酵素検査、遺伝子検査）市場規模、用途別（病院、クリニック、疾病研究・開発機関）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別ミトコンドリアミオパチー診断・治療の競争状況、市場シェア ・世界のミトコンドリアミオパチー診断・治療市場：種類別市場規模 2015年-2020年（筋肉生検、血液酵素検査、遺伝子検査） ・世界のミトコンドリアミオパチー診断・治療市場：種類別市場規模予測 2021年-2026年（筋肉生検、血液酵素検査、遺伝子検査） ・世界のミトコンドリアミオパチー診断・治療市場：用途別市場規模 2015年-2020年（病院、クリニック、疾病研究・開発機関） ・世界のミトコンドリアミオパチー診断・治療市場：用途別市場規模予測 2021年-2026年（病院、クリニック、疾病研究・開発機関） ・北米のミトコンドリアミオパチー診断・治療市場分析：米国、カナダ ・ヨーロッパのミトコンドリアミオパチー診断・治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのミトコンドリアミオパチー診断・治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のミトコンドリアミオパチー診断・治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのミトコンドリアミオパチー診断・治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：AbbVie、Centogene、GeneDx、Ixchel Pharma、Khondrion、Mitobridge、NeuroVive Pharmaceutical、Reata Pharmaceuticals、Stealth Biotherapeutics ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Mitochondrial myopathies are types of myopathies associated with mitochondrial disease. On biopsy, the muscle tissue of patients with these diseases usually demonstrate “ragged red” muscle fibers. These ragged-red fibers contain mild accumulations of glycogen and neutral lipids, and may show an increased reactivity for succinate dehydrogenase and a decreased reactivity for cytochrome c oxidase.
The identification of patients with possible MM depends upon the investigation of multiple organ dysfunction in the clinical history, examination, and clinical tests. Although there is no disease-modifying therapy for MM, there are numerous points of clinical relevance that can reduce morbidity and improve quality of life for patients with these disorders.
Market Analysis and Insights: Global Mitochondrial Myopathy Diagnosis & Treatment Market
The global Mitochondrial Myopathy Diagnosis & Treatment market size is projected to reach US$ 23 million by 2026, from US$ 21 million in 2020, at a CAGR of 5.6%% during 2021-2026.
Global Mitochondrial Myopathy Diagnosis & Treatment Scope and Market Size
Mitochondrial Myopathy Diagnosis & Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Mitochondrial Myopathy Diagnosis & Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
AbbVie
Centogene
GeneDx
Ixchel Pharma
Khondrion
Mitobridge
NeuroVive Pharmaceutical
Reata Pharmaceuticals
Stealth Biotherapeutics
Market segment by Type, the product can be split into
Muscle Biopsy
Blood Enzyme Test
Genetic Test
Market segment by Application, split into
Hospitals
Clinics
Disease Research and Development Institutes
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Mitochondrial Myopathy Diagnosis & Treatment Revenue
1.4 Market by Type
1.4.1 Global Mitochondrial Myopathy Diagnosis & Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Muscle Biopsy
1.4.3 Blood Enzyme Test
1.4.4 Genetic Test
1.5 Market by Application
1.5.1 Global Mitochondrial Myopathy Diagnosis & Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Disease Research and Development Institutes
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Mitochondrial Myopathy Diagnosis & Treatment Market Perspective (2015-2026)
2.2 Global Mitochondrial Myopathy Diagnosis & Treatment Growth Trends by Regions
2.2.1 Mitochondrial Myopathy Diagnosis & Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Mitochondrial Myopathy Diagnosis & Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Mitochondrial Myopathy Diagnosis & Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Mitochondrial Myopathy Diagnosis & Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Mitochondrial Myopathy Diagnosis & Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Mitochondrial Myopathy Diagnosis & Treatment Players by Market Size
3.1.1 Global Top Mitochondrial Myopathy Diagnosis & Treatment Players by Revenue (2015-2020)
3.1.2 Global Mitochondrial Myopathy Diagnosis & Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Mitochondrial Myopathy Diagnosis & Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Mitochondrial Myopathy Diagnosis & Treatment Market Concentration Ratio
3.2.1 Global Mitochondrial Myopathy Diagnosis & Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Mitochondrial Myopathy Diagnosis & Treatment Revenue in 2019
3.3 Mitochondrial Myopathy Diagnosis & Treatment Key Players Head office and Area Served
3.4 Key Players Mitochondrial Myopathy Diagnosis & Treatment Product Solution and Service
3.5 Date of Enter into Mitochondrial Myopathy Diagnosis & Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Mitochondrial Myopathy Diagnosis & Treatment Historic Market Size by Type (2015-2020)
4.2 Global Mitochondrial Myopathy Diagnosis & Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Mitochondrial Myopathy Diagnosis & Treatment Market Size by Application (2015-2020)
5.2 Global Mitochondrial Myopathy Diagnosis & Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Mitochondrial Myopathy Diagnosis & Treatment Market Size (2015-2020)
6.2 Mitochondrial Myopathy Diagnosis & Treatment Key Players in North America (2019-2020)
6.3 North America Mitochondrial Myopathy Diagnosis & Treatment Market Size by Type (2015-2020)
6.4 North America Mitochondrial Myopathy Diagnosis & Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Mitochondrial Myopathy Diagnosis & Treatment Market Size (2015-2020)
7.2 Mitochondrial Myopathy Diagnosis & Treatment Key Players in Europe (2019-2020)
7.3 Europe Mitochondrial Myopathy Diagnosis & Treatment Market Size by Type (2015-2020)
7.4 Europe Mitochondrial Myopathy Diagnosis & Treatment Market Size by Application (2015-2020)
8 China
8.1 China Mitochondrial Myopathy Diagnosis & Treatment Market Size (2015-2020)
8.2 Mitochondrial Myopathy Diagnosis & Treatment Key Players in China (2019-2020)
8.3 China Mitochondrial Myopathy Diagnosis & Treatment Market Size by Type (2015-2020)
8.4 China Mitochondrial Myopathy Diagnosis & Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Mitochondrial Myopathy Diagnosis & Treatment Market Size (2015-2020)
9.2 Mitochondrial Myopathy Diagnosis & Treatment Key Players in Japan (2019-2020)
9.3 Japan Mitochondrial Myopathy Diagnosis & Treatment Market Size by Type (2015-2020)
9.4 Japan Mitochondrial Myopathy Diagnosis & Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Mitochondrial Myopathy Diagnosis & Treatment Market Size (2015-2020)
10.2 Mitochondrial Myopathy Diagnosis & Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Mitochondrial Myopathy Diagnosis & Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Mitochondrial Myopathy Diagnosis & Treatment Market Size by Application (2015-2020)
11 India
11.1 India Mitochondrial Myopathy Diagnosis & Treatment Market Size (2015-2020)
11.2 Mitochondrial Myopathy Diagnosis & Treatment Key Players in India (2019-2020)
11.3 India Mitochondrial Myopathy Diagnosis & Treatment Market Size by Type (2015-2020)
11.4 India Mitochondrial Myopathy Diagnosis & Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Mitochondrial Myopathy Diagnosis & Treatment Market Size (2015-2020)
12.2 Mitochondrial Myopathy Diagnosis & Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Mitochondrial Myopathy Diagnosis & Treatment Market Size by Type (2015-2020)
12.4 Central & South America Mitochondrial Myopathy Diagnosis & Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 AbbVie
13.1.1 AbbVie Company Details
13.1.2 AbbVie Business Overview
13.1.3 AbbVie Mitochondrial Myopathy Diagnosis & Treatment Introduction
13.1.4 AbbVie Revenue in Mitochondrial Myopathy Diagnosis & Treatment Business (2015-2020))
13.1.5 AbbVie Recent Development
13.2 Centogene
13.2.1 Centogene Company Details
13.2.2 Centogene Business Overview
13.2.3 Centogene Mitochondrial Myopathy Diagnosis & Treatment Introduction
13.2.4 Centogene Revenue in Mitochondrial Myopathy Diagnosis & Treatment Business (2015-2020)
13.2.5 Centogene Recent Development
13.3 GeneDx
13.3.1 GeneDx Company Details
13.3.2 GeneDx Business Overview
13.3.3 GeneDx Mitochondrial Myopathy Diagnosis & Treatment Introduction
13.3.4 GeneDx Revenue in Mitochondrial Myopathy Diagnosis & Treatment Business (2015-2020)
13.3.5 GeneDx Recent Development
13.4 Ixchel Pharma
13.4.1 Ixchel Pharma Company Details
13.4.2 Ixchel Pharma Business Overview
13.4.3 Ixchel Pharma Mitochondrial Myopathy Diagnosis & Treatment Introduction
13.4.4 Ixchel Pharma Revenue in Mitochondrial Myopathy Diagnosis & Treatment Business (2015-2020)
13.4.5 Ixchel Pharma Recent Development
13.5 Khondrion
13.5.1 Khondrion Company Details
13.5.2 Khondrion Business Overview
13.5.3 Khondrion Mitochondrial Myopathy Diagnosis & Treatment Introduction
13.5.4 Khondrion Revenue in Mitochondrial Myopathy Diagnosis & Treatment Business (2015-2020)
13.5.5 Khondrion Recent Development
13.6 Mitobridge
13.6.1 Mitobridge Company Details
13.6.2 Mitobridge Business Overview
13.6.3 Mitobridge Mitochondrial Myopathy Diagnosis & Treatment Introduction
13.6.4 Mitobridge Revenue in Mitochondrial Myopathy Diagnosis & Treatment Business (2015-2020)
13.6.5 Mitobridge Recent Development
13.7 NeuroVive Pharmaceutical
13.7.1 NeuroVive Pharmaceutical Company Details
13.7.2 NeuroVive Pharmaceutical Business Overview
13.7.3 NeuroVive Pharmaceutical Mitochondrial Myopathy Diagnosis & Treatment Introduction
13.7.4 NeuroVive Pharmaceutical Revenue in Mitochondrial Myopathy Diagnosis & Treatment Business (2015-2020)
13.7.5 NeuroVive Pharmaceutical Recent Development
13.8 Reata Pharmaceuticals
13.8.1 Reata Pharmaceuticals Company Details
13.8.2 Reata Pharmaceuticals Business Overview
13.8.3 Reata Pharmaceuticals Mitochondrial Myopathy Diagnosis & Treatment Introduction
13.8.4 Reata Pharmaceuticals Revenue in Mitochondrial Myopathy Diagnosis & Treatment Business (2015-2020)
13.8.5 Reata Pharmaceuticals Recent Development
13.9 Stealth Biotherapeutics
13.9.1 Stealth Biotherapeutics Company Details
13.9.2 Stealth Biotherapeutics Business Overview
13.9.3 Stealth Biotherapeutics Mitochondrial Myopathy Diagnosis & Treatment Introduction
13.9.4 Stealth Biotherapeutics Revenue in Mitochondrial Myopathy Diagnosis & Treatment Business (2015-2020)
13.9.5 Stealth Biotherapeutics Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Mitochondrial Myopathy Diagnosis & Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Mitochondrial Myopathy Diagnosis & Treatment Revenue
Table 3. Ranking of Global Top Mitochondrial Myopathy Diagnosis & Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Mitochondrial Myopathy Diagnosis & Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Muscle Biopsy
Table 6. Key Players of Blood Enzyme Test
Table 7. Key Players of Genetic Test
Table 8. Global Mitochondrial Myopathy Diagnosis & Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Mitochondrial Myopathy Diagnosis & Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Mitochondrial Myopathy Diagnosis & Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Mitochondrial Myopathy Diagnosis & Treatment Market Share by Regions (2015-2020)
Table 12. Global Mitochondrial Myopathy Diagnosis & Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Mitochondrial Myopathy Diagnosis & Treatment Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Mitochondrial Myopathy Diagnosis & Treatment Market Growth Strategy
Table 18. Main Points Interviewed from Key Mitochondrial Myopathy Diagnosis & Treatment Players
Table 19. Global Mitochondrial Myopathy Diagnosis & Treatment Revenue by Players (2015-2020) (Million US$)
Table 20. Global Mitochondrial Myopathy Diagnosis & Treatment Market Share by Players (2015-2020)
Table 21. Global Top Mitochondrial Myopathy Diagnosis & Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Mitochondrial Myopathy Diagnosis & Treatment as of 2019)
Table 22. Global Mitochondrial Myopathy Diagnosis & Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Mitochondrial Myopathy Diagnosis & Treatment Product Solution and Service
Table 25. Date of Enter into Mitochondrial Myopathy Diagnosis & Treatment Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Mitochondrial Myopathy Diagnosis & Treatment Market Size by Type (2015-2020) (Million US$)
Table 28. Global Mitochondrial Myopathy Diagnosis & Treatment Market Size Share by Type (2015-2020)
Table 29. Global Mitochondrial Myopathy Diagnosis & Treatment Revenue Market Share by Type (2021-2026)
Table 30. Global Mitochondrial Myopathy Diagnosis & Treatment Market Size Share by Application (2015-2020)
Table 31. Global Mitochondrial Myopathy Diagnosis & Treatment Market Size by Application (2015-2020) (Million US$)
Table 32. Global Mitochondrial Myopathy Diagnosis & Treatment Market Size Share by Application (2021-2026)
Table 33. North America Key Players Mitochondrial Myopathy Diagnosis & Treatment Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Mitochondrial Myopathy Diagnosis & Treatment Market Share (2019-2020)
Table 35. North America Mitochondrial Myopathy Diagnosis & Treatment Market Size by Type (2015-2020) (Million US$)
Table 36. North America Mitochondrial Myopathy Diagnosis & Treatment Market Share by Type (2015-2020)
Table 37. North America Mitochondrial Myopathy Diagnosis & Treatment Market Size by Application (2015-2020) (Million US$)
Table 38. North America Mitochondrial Myopathy Diagnosis & Treatment Market Share by Application (2015-2020)
Table 39. Europe Key Players Mitochondrial Myopathy Diagnosis & Treatment Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Mitochondrial Myopathy Diagnosis & Treatment Market Share (2019-2020)
Table 41. Europe Mitochondrial Myopathy Diagnosis & Treatment Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Mitochondrial Myopathy Diagnosis & Treatment Market Share by Type (2015-2020)
Table 43. Europe Mitochondrial Myopathy Diagnosis & Treatment Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Mitochondrial Myopathy Diagnosis & Treatment Market Share by Application (2015-2020)
Table 45. China Key Players Mitochondrial Myopathy Diagnosis & Treatment Revenue (2019-2020) (Million US$)
Table 46. China Key Players Mitochondrial Myopathy Diagnosis & Treatment Market Share (2019-2020)
Table 47. China Mitochondrial Myopathy Diagnosis & Treatment Market Size by Type (2015-2020) (Million US$)
Table 48. China Mitochondrial Myopathy Diagnosis & Treatment Market Share by Type (2015-2020)
Table 49. China Mitochondrial Myopathy Diagnosis & Treatment Market Size by Application (2015-2020) (Million US$)
Table 50. China Mitochondrial Myopathy Diagnosis & Treatment Market Share by Application (2015-2020)
Table 51. Japan Key Players Mitochondrial Myopathy Diagnosis & Treatment Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Mitochondrial Myopathy Diagnosis & Treatment Market Share (2019-2020)
Table 53. Japan Mitochondrial Myopathy Diagnosis & Treatment Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Mitochondrial Myopathy Diagnosis & Treatment Market Share by Type (2015-2020)
Table 55. Japan Mitochondrial Myopathy Diagnosis & Treatment Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Mitochondrial Myopathy Diagnosis & Treatment Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Mitochondrial Myopathy Diagnosis & Treatment Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Mitochondrial Myopathy Diagnosis & Treatment Market Share (2019-2020)
Table 59. Southeast Asia Mitochondrial Myopathy Diagnosis & Treatment Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Mitochondrial Myopathy Diagnosis & Treatment Market Share by Type (2015-2020)
Table 61. Southeast Asia Mitochondrial Myopathy Diagnosis & Treatment Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Mitochondrial Myopathy Diagnosis & Treatment Market Share by Application (2015-2020)
Table 63. India Key Players Mitochondrial Myopathy Diagnosis & Treatment Revenue (2019-2020) (Million US$)
Table 64. India Key Players Mitochondrial Myopathy Diagnosis & Treatment Market Share (2019-2020)
Table 65. India Mitochondrial Myopathy Diagnosis & Treatment Market Size by Type (2015-2020) (Million US$)
Table 66. India Mitochondrial Myopathy Diagnosis & Treatment Market Share by Type (2015-2020)
Table 67. India Mitochondrial Myopathy Diagnosis & Treatment Market Size by Application (2015-2020) (Million US$)
Table 68. India Mitochondrial Myopathy Diagnosis & Treatment Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Mitochondrial Myopathy Diagnosis & Treatment Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Mitochondrial Myopathy Diagnosis & Treatment Market Share (2019-2020)
Table 71. Central & South America Mitochondrial Myopathy Diagnosis & Treatment Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Mitochondrial Myopathy Diagnosis & Treatment Market Share by Type (2015-2020)
Table 73. Central & South America Mitochondrial Myopathy Diagnosis & Treatment Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Mitochondrial Myopathy Diagnosis & Treatment Market Share by Application (2015-2020)
Table 75. AbbVie Company Details
Table 76. AbbVie Business Overview
Table 77. AbbVie Product
Table 78. AbbVie Revenue in Mitochondrial Myopathy Diagnosis & Treatment Business (2015-2020) (Million US$)
Table 79. AbbVie Recent Development
Table 80. Centogene Company Details
Table 81. Centogene Business Overview
Table 82. Centogene Product
Table 83. Centogene Revenue in Mitochondrial Myopathy Diagnosis & Treatment Business (2015-2020) (Million US$)
Table 84. Centogene Recent Development
Table 85. GeneDx Company Details
Table 86. GeneDx Business Overview
Table 87. GeneDx Product
Table 88. GeneDx Revenue in Mitochondrial Myopathy Diagnosis & Treatment Business (2015-2020) (Million US$)
Table 89. GeneDx Recent Development
Table 90. Ixchel Pharma Company Details
Table 91. Ixchel Pharma Business Overview
Table 92. Ixchel Pharma Product
Table 93. Ixchel Pharma Revenue in Mitochondrial Myopathy Diagnosis & Treatment Business (2015-2020) (Million US$)
Table 94. Ixchel Pharma Recent Development
Table 95. Khondrion Company Details
Table 96. Khondrion Business Overview
Table 97. Khondrion Product
Table 98. Khondrion Revenue in Mitochondrial Myopathy Diagnosis & Treatment Business (2015-2020) (Million US$)
Table 99. Khondrion Recent Development
Table 100. Mitobridge Company Details
Table 101. Mitobridge Business Overview
Table 102. Mitobridge Product
Table 103. Mitobridge Revenue in Mitochondrial Myopathy Diagnosis & Treatment Business (2015-2020) (Million US$)
Table 104. Mitobridge Recent Development
Table 105. NeuroVive Pharmaceutical Company Details
Table 106. NeuroVive Pharmaceutical Business Overview
Table 107. NeuroVive Pharmaceutical Product
Table 108. NeuroVive Pharmaceutical Revenue in Mitochondrial Myopathy Diagnosis & Treatment Business (2015-2020) (Million US$)
Table 109. NeuroVive Pharmaceutical Recent Development
Table 110. Reata Pharmaceuticals Business Overview
Table 111. Reata Pharmaceuticals Product
Table 112. Reata Pharmaceuticals Company Details
Table 113. Reata Pharmaceuticals Revenue in Mitochondrial Myopathy Diagnosis & Treatment Business (2015-2020) (Million US$)
Table 114. Reata Pharmaceuticals Recent Development
Table 115. Stealth Biotherapeutics Company Details
Table 116. Stealth Biotherapeutics Business Overview
Table 117. Stealth Biotherapeutics Product
Table 118. Stealth Biotherapeutics Revenue in Mitochondrial Myopathy Diagnosis & Treatment Business (2015-2020) (Million US$)
Table 119. Stealth Biotherapeutics Recent Development
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Mitochondrial Myopathy Diagnosis & Treatment Market Share by Type: 2020 VS 2026
Figure 2. Muscle Biopsy Features
Figure 3. Blood Enzyme Test Features
Figure 4. Genetic Test Features
Figure 5. Global Mitochondrial Myopathy Diagnosis & Treatment Market Share by Application: 2020 VS 2026
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Disease Research and Development Institutes Case Studies
Figure 9. Mitochondrial Myopathy Diagnosis & Treatment Report Years Considered
Figure 10. Global Mitochondrial Myopathy Diagnosis & Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Mitochondrial Myopathy Diagnosis & Treatment Market Share by Regions: 2020 VS 2026
Figure 12. Global Mitochondrial Myopathy Diagnosis & Treatment Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Mitochondrial Myopathy Diagnosis & Treatment Market Share by Players in 2019
Figure 15. Global Top Mitochondrial Myopathy Diagnosis & Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Mitochondrial Myopathy Diagnosis & Treatment as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Mitochondrial Myopathy Diagnosis & Treatment Revenue in 2019
Figure 17. North America Mitochondrial Myopathy Diagnosis & Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Mitochondrial Myopathy Diagnosis & Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Mitochondrial Myopathy Diagnosis & Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Mitochondrial Myopathy Diagnosis & Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Mitochondrial Myopathy Diagnosis & Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Mitochondrial Myopathy Diagnosis & Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Mitochondrial Myopathy Diagnosis & Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed
ミトコンドリアミオパチーの世界市場（～2026年） Mitochondrial myopathies are types of myopathies associated with mitochondrial disease. On biopsy, the muscle tissue of patients with these diseases usually demonstrate "ragged red" muscle fibers. These ragged-red fibers contain mild accumulations of glycogen and neutral lipids, and may show an incr…- HIV診断・治療の世界市場（～2026年） HIV prevalence in Africa, specifically in Southern region is very high as compared to North African region. Approximately 1 out of 4 is suffering from HIV. Southern and Eastern region of Africa has one of the highest prevalence rate of HIV, about 19 million people have HIV. While HIV prevalence is l…
- 癲癇診断・治療の世界市場（～2026年） Epilepsy is a neurological disorder affecting the central nervous system. In this medical condition, the brain exhibits abnormal activity, which results in periods of unusual behavior or seizures and sometimes, loss of awareness. Temporary confusion, anxiety, uncontrollable jerking movements of the …
- クラミジア診断・治療の世界市場（～2026年） Chlamydia trachomatis is a type of sexually transmitted disease that is prevalent in population of all age group, but women are much more vulnerable to it. The Chlamydia diagnosis involves a series of test such as urine culture, The change in lifestyle especially related to sex preferences is the ma…
- 髄膜炎診断・治療の世界市場（～2026年） Meningitis is an acute inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges. The most common symptoms are fever, headache, and neck stiffness. Other symptoms include confusion or altered consciousness, vomiting, and an inability to tolerate …